Isabel Kalofonos
SVP & CHIEF COMMERCIAL OFFICER, ImmunoGen Inc.
Companies
- Crinetics PharmaceuticalsChief Commercial Officer Dec 30, 2024 to now1
- ImmunoGen Inc.SVP & CHIEF COMMERCIAL OFFICER May 2, 2023 to Feb 12, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Crinetics Pharmaceuticals0 shares3Sep 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Returned to company 34,000 shares at $85.00 of Crinetics Pharmaceuticals3
- Sep 1, 2026Returned to company 1,669 shares at $85.00 of Crinetics Pharmaceuticals3
- Feb 23, 2026Granted 34,000 shares of Crinetics Pharmaceuticals4
- Jan 5, 2026Sold 2,500 shares at $55.00 of Crinetics Pharmaceuticals5
- Jan 5, 2026Exercised options 2,500 shares at $40.59 of Crinetics Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 25, 2026
- 5SEC EDGARForm 4 filed Jan 7, 2026